
The study unveils a novel mechanism to explain contradictory actions of androgens in prostate cancer, offering promising potential in managing prostate cancer more effectively.
In 2022, an estimated 14,100 new cases of invasive cervical cancer were diagnosed in the United States, according to the American Cancer Society.
Stay up to date on the latest news from our providers, facilities and researchers at USA Health.
The study unveils a novel mechanism to explain contradictory actions of androgens in prostate cancer, offering promising potential in managing prostate cancer more effectively.
The award is part of the NASA-funded institute’s Biomedical Research Advances for Space Health solicitation, which invests in emerging science with the potential to reduce risks to human health and performance during deep-space exploration.
The highly competitive grants provide each researcher $50,000 in funding per year for two years. The awards function as seed funding for early-stage studies, allowing researchers to generate the additional data needed to attract major national funding.
The findings by scientists and physicians at the Mitchell Cancer Institute could be useful in developing a non-invasive test for pancreatic cancer diagnosis.
Cancer researcher Aishwarya Prakash, Ph.D., was named the recipient of the Mayer Mitchell Award for Excellence in Cancer Research on Tuesday, Nov. 15, 2022, at the USA Health Mitchell Cancer Institute.
Their presentation – which highlights the breadth of capabilities at USA Health for burn patients – demonstrates the benefits of a collaborative care approach across the inpatient and outpatient setting.
Jennifer Young Pierce, M.D., M.P.H., will give an oral presentation outlining the results of a study that looked at positive results of cancer survivors who participated in culinary medicine classes.
Known as the GeneSwap approach, this new technology provides novel insights into mitochondrial diseases, which are often lethal and have only palliative treatments available.
Seema Singh, Ph.D., is a professor of pathology at the Whiddon College of Medicine and a senior member of the cancer biology program at the USA Health Mitchell Cancer Institute.
“Our preliminary studies make strong suggestions for a pathobiological involvement of nicotine exposure in prostate cancer aggressiveness and therapy resistance.”
Glen Borchert, Ph.D., associate professor of pharmacology, is studying the survival of Salmonella bacteria during cellular stress.
The gift includes $23,900 in proceeds from the recent Piggly Wiggly Golf Tournament in Mobile and a matching donation from longtime MCI supporter Abraham A. Mitchell.